Abstract
Immune related adverse events (irAEs) are one of the leading causes of discontinuation of cancer immunotherapy treatment. Despite extensive research into the frequency and types of irAEs, little is known about the cell types and pathways through which these drugs cause the observed side effects. To identify cell types and pathways of interest, we have analyzed single cell sequencing data of PBMCs from patients who developed skin irAEs as a result of their immunotherapy treatment. Using Azimuth’s cell type identification software for PBMCs and GSEA pathway analysis, we found macrophage cell populations and reactive oxygen species related pathways to be upregulated. These results provide important groundwork to build a complete picture of the mechanisms which cause irAEs and finding ways to more effectively treat them.
Funder
The Cancer Research Institute, Clinic & Laboratory Integration Program (CLIP), The Collins Medical Trust, The American Cancer Society
The Department of Defense (DOD) Congressionally Directed Medical Research Program
The Melanoma Research Alliance
The OHSU Physician-Scientist Program
Cancer Advanced Research Early Detection Center (CEDAR) at OHSU